New global health research hub. Korea-based vaccine developer to establish branch office in Stockholm
NewsJanuary 12, 2022
/ By: Ann Danaiya Usher
The international organisation IVI headquartered in Seoul, which develops vaccines for poor-country diseases, has signed a memorandum of understanding with the Swedish government on setting up a regional office in Stockholm. The office will “help Sweden and Europe create an international hub for global health research” and IVI hopes to expand its donor base.
The rest of the content is only available for subscribers.